JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Surgery Section DOI : 10.7860/JCDR/2019/42836.13345
Year : 2019 | Month : Dec | Volume : 13 | Issue : 12 Full Version Page : PC01 - PC05

An Audit of Andrological Needs in Traumatic Paraplegic Male Patients: Five Year Assessment in a Single Paraplegic Centre

Prakash Pawar1, Sunil Patil2, Ashwin Tamhankar3, Vijay Kulkarni4, Abhishek Savalia5, Neel Shah6, Swaroop Subbaraya7

1 Associate Professor, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.
2 Assistant Professor, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.
3 Consultant Urologist, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.
4 Honorary Consultant, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.
5 Consultant Urologist, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.
6 Resident, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.
7 Resident, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai, Maharashtra, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Sunil Patil, Room No. 219, Department of Urology, Lokmanya Tilak Medical College and General Hospital, Mumbai-22, Maharashtra, India.
E-mail: sunil7887@gmail.com
Abstract

Introduction

Management of andrological needs of paraplegic patients is challenging and has to be individualised.

Aim

To analyse demographic profile and treatment responses with respect to the andrological needs in Traumatic Spinal Cord Injury (TSI) patients over five years in a single paraplegic centre.

Materials and Methods

Records of 110 patients admitted for TSI over a period of five years were studied. Demographic parameters considered were age, marital and fertility status, mode of trauma, socioeconomic status. Patients were assessed by American Spinal Injury Association Impairment Scale (AIS) and International Index of Erectile Function score (IIEF5). Erectile Dysfunction (ED) and Ejaculatory Dysfunctions (EJD) were primarily targeted for interventions. Treatment options included were Phosphodiesterase-5 inhibitors (PDE-5i), Intracavernosal Injections of Vasoactive Drugs (ICIVAD) and Vacuum Erection Devices (VED) for ED; Penile Vibrator Stimulation (PVS) and Electroejaculation (EEJ) for EJD. All the interventions were also accompanied by psychosexual counseling. The proportion of patients responding to each therapy was noted. Paired t-test was used to compare the IIEF score in patients with ED before and after therapy.

Results

Seventy four patients were addressed for ED. The mean age was 31.3±7.8 years; 58 of 74 patients were compliant for PDE-5 inhibitors; 42 patients out of these were satisfied with oral PDE-5i therapy. Out of 12 patients who opted for ICIVAD, 10 were satisfied with the outcome. Out of 16 patients treated by VED, 5 deemed their erections as satisfactory. The mean IIEF-5 score before therapy was 8. The mean IIEF-5 score as a result of the combined therapy was 12.3 (p<0.01). Total 16 patients had EJD, out of which 5 had successful ejaculation after PVS. One patient underwent successful Electro-ejaculation.

Conclusion

A step-by-step approach of oral PDE-5i therapy, ICIVAD and VED is adequate to manage ED in a majority of patients with SCI. Similarly, PVS and EEJ can be used for management of EJD in these patients.

Keywords

Introduction

Traumatic Spinal Cord Injury (TSI) is a devastating problem which is being faced by many young patients all over the globe. In India 10,000 new cases are added every year [1,2]. Majority of them are from 16-30 years age group [1]. These patients face multiple andrology related problems in terms of ED, anejaculation, anorgasmia and infertility [3].

These patients also suffer from many physical and psychological issues [4], which eventually make the management of andrological aspects difficult. It has been found that ED is the main cause of psychological distress in Spinal Cord Injury (SCI) patients [3].

There have been studies which emphasise the need to manage sexual dysfunction in such patients to treat them holistically [4]. In a literature review conducted by Sunilkumar MM et al., it was inferred that, further research on how men themselves view their sexual disabilities would go a long way in planning of adequate treatment and rehabilitation [4]. A systemic review by Deforge D et al., found the need to study the long-term sexual adjustment and holistic approaches in these patients [5]. Moreover, there is a lack of large scale studies, having long follow-up, regarding sexual functioning in spinal cord injuries in the Indian setting [6]. This study was hence conducted with an attempt to study the efficacy of various treatment options for ED and EJD in patients of TSI and compare the long-term outcomes in Indian setting.

Materials and Methods

A retrospective study of patients with TSI, admitted in The Paraplegic Foundation, Mumbai from September 2011 to August 2016 was conducted.

Hospital ethics committee approval was taken for the study (IEC/04/16). Included patients were those with age more than 18 years of age with lesion below T6 level. Patients permanently on catheter (not willing for CISC) and those not willing to participate in the study were excluded.

Demographic and andrological parameters of all these patients were noted. The records of patients before and after therapy were compared.

The Department of Urology of the study hospital takes care of urological and andrology related aspects of patients admitted in ‘The Paraplegic Foundation’, Mumbai which was established in 1968. It is a multidisciplinary team approach which consists of urologist, internist, psychiatrist, microbiologist, physiotherapist, nursing staff, and health care providers.

Total patients admitted at a time in the foundation are approximately 35. Around 30 were males and 5 were females. On an average, one patient stays for 6-9 months till complete rehabilitation. From urology perspective, all patients were evaluated for their symptoms and examined in detail. History about demographic parameters, mode of injury, duration, family issues, fertility status, and andrological aspects were considered in detail. History about andrological issues consists of details of libido, arousal, masturbatory or sexual or morning erections, rigidity and duration of erections, ability for penetration, orgasm and details of ejaculation. Relevant history was also considered from spouse. Psychiatrists were actively involved in this process. Patients were evaluated for American Spinal Injury Association Impairment Scale [7,8] for their sensory and motor functions. For ED, all patients were evaluated with IIEF-5 [9] score and classified as mild to severe ED depending on the scores. These records were maintained in the case files.

Majority of patients at the time of admission were on catheter which is present for variable amount of time before admission. Urinary infections were treated as per the cultures. Baseline evaluation was done in the form of ultrasound abdomen, post-void residue, and urodynamic testing whenever indicated. Gradually, patients were taught about Clean Intermittent Self-Catheterization (CISC) and motivated for getting off catheter. Once patient is off catheter, his treatment goals are decided for ED and/or EJD depending upon the willingness to father a child.

Those patients who wish to be treated for ED after proper counselling were started on treatment. Patients were started on Phosphodiesterase-5 inhibitors (PDE-5i): Tab Tadalafil 5 mg daily and 20 mg on demand 2 hours before the activity after ruling out necessary contraindications. Visual stimulation was used wherever required. If the patient fail on above treatment, second line treatment was considered, which consists of ICIVAD. Bimix solution (used for ICIVAD) consists of Injection papaverine 4 mL (30 mg/mL) plus Injection chlorpromazine 0.1 mL (0.625 mg/mL) [10]. The solution was injected starting from a minimum dose of 0.1 mL. The dose was titrated as per the requirement, upto a maximum of 1.0 mL under supervision. Patient and/or spouse were taught to administer the dose with 30G needle in corpora cavernosa [Table/Fig-1]. Motivated patients were also encouraged for homeself-injections. Contraindications like uncontrolled coagulopathy, unstable cardiovascular disease, and psychogenic instability were ruled out before administering ICIVAD. Patients were explained about risk of priapism, and the possibility of emergent treatment in the emergency department, if it occurs. Along with these treatment options, motivated patients were also offered VED and taught about the necessary precautions during the use. Penile implants were not offered to our patients in this center as there are multiple risk factors for complications and extrusions, in the form of sensory loss, local infections and need for CISC. For EJD, treatments offered are PVS using a vibrator or EEJ using Saegar’s model (Dalzell USA Medical Systems, Dungannon, Northern Ireland). Inexpensive models of vibrators are used which have similar frequency of 110 Hz and 2.5 mm amplitude [Table/Fig-2]. Cycles of stimulation of 3-5 min followed by rest for 2 min are repeated for a maximum of 1 hour. For those who do not respond to vibrator therapy, EEJ was performed under anaesthesia with progressively increasing voltage from 5 V to 25 V with a current of 100-600 mA in intermittent manner. Non-catheterized sample of semen was collected for cryopreservation.

Technique of Intracavernosal Injection of Vasoactive Drug (ICIVAD).

Low cost vibrator used for PVS.

Results

Out of 167 patient records assessed during this study period, 110 met the inclusion criteria.

The demographic data of these patients is shown in [Table/Fig-3]. The mean age was 34 years with standard deviation of 9.39 years. The details of spinal cord injuries are given in [Table/Fig-4]. Severe and moderate ED was present in 50.9% and 30.9% patients. Mild to moderate and mild ED was present in 12.7% and 5.4% patients, respectively. The mean IIEF-5 score of the total population was 8.53 [Table/Fig-5].

Demographic data of patients.

ParameterTotal populationStudy population
Age group20-30 years4740
30-40 years3322
40-50 years2311
50-60 years71
Marital statusMarried with completed family5021
Married with family not complete1613
Unmarried4440
Educational statusPrimary education6843
Secondary education2314
Higher secondary education1816
Graduate and above11

Details of spinal cord injury.

ParameterTotal populationStudy population
Cause of InjuryRTA7752
Fall from height1915
Assault137
Miscellaneous10
Injury levelT6-T732
T7-T844
T8-T973
T9-T10129
T10-T111611
T11-T122719
T12-L12315
L1-L2117
L2-L3 and lower74
ASIA impairment scaleA3118
B4231
C2719
D96
E10

IIEF-5 scores in each category.

IIEF-5 CategoryTotal populationStudy population
Scores before therapyScores after therapy
No ED (22-25)001
Mild ED (17-21)615
Mild to moderate ED (12-16)14917
Moderate ED (8-11)342533
Severe ED (5-7)563918

After complete counseling and evaluations, patients motivated for treatment of ED were 74 out of 110 (67%). The mean age group of these patients was 31.3 years with a standard deviation of 7.8 years. The mean IIEF-5 score before therapy in these patients was 8. Sixteen out of 110 (14.5%) patients were concerned about treatment of anejaculation.

All 74 patients of ED were started on treatment but only 58 of them were compliant for the same. They were on 5 mg Tadalafil once a day with on-demand use of 10 mg or 20 mg as per the effect. Forty two out of 58 (72.4%) had satisfactory erections with PDE-5 inhibitors. Thirteen (22.4%) of them could have successful ejaculation. Certain patients had side effects in the form of body aches. No visual problems occurred in them.

Five out of 16 patients who were not satisfied with PDE-5i therapy and 7 out 16 who were not compliant for PDE-5i therapy (i.e., a total of 12 patients) opted for ICIVAD [Table/Fig-6]. They were continued on PDE-5 inhibitors along with injections as and when required. Average time for full erection was 15 minutes and average dose required was 0.2cc Bimix. Ten of 12 (83.3%) had penetrable erections. Six (50%) had successful ejaculations. Though a small number, overall response was poor with lumbosacral lesions as compared to higher lesions. Three patients were on home self-injections. Ten out of these patients were satisfied with the outcome.

Flowchart showing type of therapy given to patients of ED.

Another 7 out of the patients not successful after PDE-5i, 8 of those not compliant on oral drugs along with a patient not satisfied after ICIVAD (i.e., a total of 16 patients) opted for VED with PDE-5i or ICIVAD. Five of these patients deemed their erections to be satisfactory.

The mean follow-up was 4.6 years. (Maximum follow-up: 7.5 years, Minimum follow-up: 3.8 years).

The mean IIEF-5 score as a result of the combined therapy was 12.3, as compared to 8 before starting therapy (p<0.01) [Table/Fig-5]. Out of all patients treated for ED, a total of 57 patients (77%) had an erection which they considered satisfactory.

Total 16 patients who were concerned about EJD had penile vibratory stimulations. Five of which could have ejaculation. They were asked to go ahead with IUI (Intra-uterine Insemination) if the semen parameters were appropriate. Only one patient out of those not successful on PVS, opted for EEJ. It was done in an in-patient setting, under anesthesia. The semen sample obtained after EEJ was found to have oligozoospermia. None of the patients were affording for ICSI or cryopreservation. Though few of them tried for IUI, none had successful pregnancy as the outcome.

Discussion

An improvement of IIEF-5 score from 8 to 12.3 (p<0.01) was observed in the study; 77% of patients treated for ED had an erection which was deemed satisfactory by them. Biering-Sørensen I et al., conducted a similar study in which 78-94% of men with TSI had positive effects of penile vibration, drugs and intracavernous injection for erection [11]. Similarly, Del Popolo G et al., reported an improvement of mean IIEF scores of 3.5 to 6.6 in patients treated by PDE-5i for ED [12]. This is in concordance with the improvement in the mean IIEF-5 scores in this study.

Guttman L have described three phases for erectile functions after spinal injury in the form of spinal shock, reflex return and readjustment [13]. In the shock phase, there may not be any erections, in second phase there is reflex return of functions and the final phase depends majorly on the pre-injury functions and rehabilitation. After injury, reflexogenic erections can occur after cutaneous stimulation below the level of lesion which requires intact sacral reflex arc. Psychogenic erections can occur because of audio-visual stimuli [14]. Few authors consider that patients with incomplete injury are better for assessment of erectile functions than complete lesions [15]. Correlation has also been established for the spinal level of lesion and the erectile function. It has been reported that higher lesions with intact local parasympathetic arc have better function as compared to lower lesions with damaged sacral arc [16]. Although it has also been mentioned that level and completeness of lesion has no effect on sexual outcomes after TSI [17]. Overall ability of erection varies from 54% to 95% and ability for successful coitus varies from 5% to 75% [18].

It has been studied that the effect of PDE-5 inhibitors is more if there is a sparing of sacral or thoracolumbar segments in cases with spinal injury [19]. Word of caution for the patients who are on PDE-5 inhibitors is to avoid nitrates for the treatment of autonomic dysreflexia which can occur in them. Virag R introduced intracavernosal injection of vasoactive agent (papaverine) for the first time in 1982 [20]. After that multiple agents have been used. We prefer a combination of Papaverine and chlorpromazine [10]. It is a cost effective alternative of prostaglandins in developing countries without any specific side effects. The site of injection should be alternate on both corpora on lateral aspect to avoid chances of fibrosis [21]. Overall the treatment response to oral or intracavernosal agents is better in these patients due to the fact that they have predominantly neurological ED with intact healthy vascularity maintained in cavernosal tissues [21]. Penile implants have been tried in past in TSI patients for reasons of erection, ease of CISC and ease of condom type catheter application [22,23]. Multiple series report against use of implants in these patients with higher rates of erosion or extrusion in the range of 10-25% [24]. Because of lack of sensation, there is delay in identification and salvage of implant related infective complications [25].

PVS as the modality for ejaculation was demonstrated by Sobrero AJ et al., [26]. PVS action depends on the integrity of dorsal penile nerve and sacral reflex arc. Authors have mentioned that intactness of bulbocavernous reflex (S2-S4) [27] or hip flexion reflex (L2-S1) [28] predicts favourable response to PVS. The vibrator which we use is an inexpensive variety of the standard one and has good outcomes in our small set of patients. EEJ was first time demonstrated in 1931 by Learmonth JR, and modification was introduced in 1987 by Halstead LS et al., [29,30]. Various precautions during EEJ have been standardised in the form of catheterisation before procedure, check anoscopy before and after the procedure, catheterised or non-catheterised collection of sample with preservative medium (Ham’s F 10). Interrupted current delivery is considered to be better than continuous one for obtaining good numbers and quality [31]. It has been reported that EEJ is useful for obtaining ejaculation in patients with all types of SCI in spite of loss of ejaculatory reflex arc [32]. Authors have demonstrated rates of 80% to 100% for induction of ejaculation with EEJ in spinal cord injured patients [33].

In spite of positive results in terms of ejaculation with the use of different modalities, overall semen parameters in these patients are of poor quality; aetiology of which is multifactorial [34]. Testicular function is abnormal because of abnormal HPG axis and testicular fibrosis leading to maturation arrest. Epididymal and testicular hypofunction occurs because of increased temperature. Seminal content also has high reactive oxygen species, leukocytes, inhibitory cytokines and structural defects in sperms. A study reported that inactivation of the inhibitory cytokines (IL-6, IL 1 beta, TNF alpha) by monoclonal antibodies enhances sperm motility [35]. Basic research for improvement of all parameters in paraplegic patient is on-going throughout the globe. Neuro-prostheses are also tried which are the devices that use electrodes to interact with neurological system for restoration of function especially in SCI patients [36]. Although in the experimental stage, these experiments can be the future for paraplegic patients. A meta-analysis mentioned that stem cell therapy for cavernous injured rats increases intra-cavernosal pressures and prove the validity and safety of stem cells for neurological ED in rat model [37]. We considered this project as a part of complete rehabilitation of our patients from “Paraplegic foundation.”

Limitation

Although overall sample size in this study was small, the patients had significant improvement in different aspects of sexuality. The study was retrospective in nature with a small sample size, especially those patients who were treated for EJD were less.

Conclusion

A step-by-step approach of oral PDE-5i therapy, ICIVAD and VED is adequate to manage ED in a majority of patients with SCI. Similarly, PVS and EEJ can be used for management of EJD in these patients. These modalities are efficacious as well as cost-effective for long-term management of these patients in Indian settings.

References

[1]Gupta N, Solomon NJ, Raja K, Demographic characteristics of individuals with paraplegia in India- A survey Indian Journal of Physiotherapy and Occupational Therapy 2008 2(3):24-27.  [Google Scholar]

[2]Ning GZ, Wu Q, Li YL, Feng SQ, Epidemiology of traumatic spinal cord injury in Asia: A systematic review J Spinal Cord Med 2012 35(4):229-39.10.1179/2045772312Y.000000002122925749  [Google Scholar]  [CrossRef]  [PubMed]

[3]Barbonetti A, Cavallo F, Felzani G, Francavilla S, Francavilla F, Erectile dysfunction is the main determinant of psychological distress in men with spinal cord injury J Sex Med 2012 9(3):830-36.10.1111/j.1743-6109.2011.02599.x22188659  [Google Scholar]  [CrossRef]  [PubMed]

[4]Sunilkumar MM, Boston P, Rajagopal MR, Sexual functioning in men living with a spinal cord injury- A narrative literature review Indian J Palliat Care 2015 21(3):274-81.10.4103/0973-1075.16488626600694  [Google Scholar]  [CrossRef]  [PubMed]

[5]Deforge D, Blackmer J, Garritty C, Yazdi F, Cronin V, Barrowman N, Male erectile dysfunction following spinal cord injury: A systematic review Spinal Cord 2006 44(8):465-73.Epub 2005 Nov 2910.1038/sj.sc.310188016317419  [Google Scholar]  [CrossRef]  [PubMed]

[6]Sunilkumar M, Boston P, Rajagopal M, Views and attitudes towards sexual functioning in men living with spinal cord injury in Kerala, South India Indian J Palliat Care 2015 21(1):12-20.10.4103/0973-1075.15015825709179  [Google Scholar]  [CrossRef]  [PubMed]

[7]Standards for neurological classification of spinal injury patients, American Spinal Injury Association-Chicago: American Spinal Injury Association, 1984  [Google Scholar]

[8]Roberts TT, Leonard GR, Cepela DJ, Classifications In Brief: American Spinal Injury Association (ASIA) Impairment scale Clin Orthop Relat Res 2017 475(5):1499-504.10.1007/s11999-016-5133-427815685  [Google Scholar]  [CrossRef]  [PubMed]

[9]Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A, The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction Urology 1997 49:822-30.10.1016/S0090-4295(97)00238-0  [Google Scholar]  [CrossRef]

[10]Kulkarni V, Shah R, Gupte D, Mehta M, A clinical study of erection inducing effects of intracavernosal chlorpromazine International Journal of Impotence Research 1996 Nov Special issue 7th World meeting on impotence, San Francisco  [Google Scholar]

[11]Biering-Sørensen I, Hansen RB, Biering-Sørensen F, Sexual function in a traumatic spinal cord injured population 10-45 years after injury J Rehabil Med 2012 44(11):926-31.10.2340/16501977-105723027201  [Google Scholar]  [CrossRef]  [PubMed]

[12]Del Popolo G, Marzi VL, Mondaini N, Lombardi G, Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients Spinal Cord 2004 42(11):644-48.10.1038/sj.sc.310161715289800  [Google Scholar]  [CrossRef]  [PubMed]

[13]Guttmann L, The sexual problem (Chapter 29) In: Spinal cord injuries. Comprehensive management and research 1976 2nd edOxford, London, Edinburgh, MelbourneBlackwell Scientific Publications:474-505.  [Google Scholar]

[14]Biering-Sørensen F, Sønksen J, Sexual function in spinal cord lesion Spinal Cord 2001 39:455-70.10.1038/sj.sc.310119811571657  [Google Scholar]  [CrossRef]  [PubMed]

[15]Tay HP, Juma S, Joseph AC, Psychogenic impotence in spinal cord injury patients Arch Phys Med Rehabil 1996 77:391-93.10.1016/S0003-9993(96)90090-8  [Google Scholar]  [CrossRef]

[16]Griffith ER, Tomoko MA, Timms RJ, Sexual function in spinal cord-injured patients: a review Arch Phys Med Rehabil 1973 54:539-43.  [Google Scholar]

[17]Siösteen A, Lundqvist C, Blomstrand C, Sullivan L, Sullivan M, Sexual ability, activity, attitudes and satisfaction as part of adjustment in spinal cord-injured subjects Paraplegia 1990 28:265-70.10.1038/sc.1990.382235037  [Google Scholar]  [CrossRef]  [PubMed]

[18]Biering-Sorensen F, Sonksen J, Penile erection in men with spinal cord or caudaequina lesions: A review Semin Neurol 1992 12:98-105.10.1055/s-2008-10411621502437  [Google Scholar]  [CrossRef]  [PubMed]

[19]Schmid DM, Schurch B, Hauri D, Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients Eur Urol 2000 38:184-93.10.1159/00002027810895011  [Google Scholar]  [CrossRef]  [PubMed]

[20]Virag R, Intracavernous injection of papaverine for erectile failure (Letter to the editor) Lancet 1982 2:93810.1016/S0140-6736(82)90910-2  [Google Scholar]  [CrossRef]

[21]Lloyd LK, Richards JS, Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury Paraplegia 1989 27:457-64.10.1038/sc.1989.722608299  [Google Scholar]  [CrossRef]  [PubMed]

[22]Arsdalen KNV, Klein FA, Hackler RH, Brady SM, Penile implants in spinal cord injury patients for maintaining external appliances J Urol 1981 121:288-89.  [Google Scholar]

[23]Iwatsubo E, Tanaka M, Takahashi K, Akatsu T, Non-inflatable penile prosthesis for the management of urinary incontinence and sexual disability of patients with spinal cord injury Paraplegia 1986 24:307-10.10.1038/sc.1986.433774367  [Google Scholar]  [CrossRef]  [PubMed]

[24]Dietzen CJ, Lloyd LK, Complications of intracavernous injections and penile prostheses in spinal cord injured men Arch Phys Med Rehabil 1992 73:652-55.  [Google Scholar]

[25]Padma-Nathan H, Kanellos A, The management of erectile dysfunction following spinal cord injury Semin Urol 1992 10(2):133-37.  [Google Scholar]

[26]Sobrero AJ, Stearns HE, Blair JH, Technic for the induction of ejaculation in humans Fertility and Sterility 1965 16(6):765-67.10.1016/S0015-0282(16)35767-3  [Google Scholar]  [CrossRef]

[27]Szasz G, Carpenter C, Clinical observations in vibratory stimulation of the penis of men with spinal cord injury Archives of Sexual Behavior 1989 18(6):461-74.10.1007/BF015416732604539  [Google Scholar]  [CrossRef]  [PubMed]

[28]Brindley GS, The fertility of men with spinal injuries Paraplegia 1984 22:337-48.10.1038/sc.1984.566335235  [Google Scholar]  [CrossRef]  [PubMed]

[29]Learmonth JR, A contribution to the neurophysiology of the urinary bladder in man Brain 1931 54:147-76.10.1093/brain/54.2.147  [Google Scholar]  [CrossRef]

[30]Halstead LS, Ver Voort S, Seager SWJ, Rectal probe electrostimulation in the treatment of anejaculatory spinal cord injured men Paraplegia 1987 25:120-29.10.1038/sc.1987.213495772  [Google Scholar]  [CrossRef]  [PubMed]

[31]Brackett NL, Ead DN, Aballa TC, Ferrell SM, Lynne CM, Semen retrieval in men with spinal cord injury is improved by interrupting current delivery during electroejaculation J Urol 2002 167(1):201-03.10.1016/S0022-5347(05)65412-2  [Google Scholar]  [CrossRef]

[32]Ohl DA, Sønksen J, Current status of electroejaculation Adv Urol 1997 10:169-89.  [Google Scholar]

[33]Nehra A, Werner MA, Bastuba M, Title C, Oates RD, Vibratory stimulation and rectal probe electroejaculation as therapy for patients with spinal cord injury: Semen parameters and pregnancy rates J Urol 1996 155:554-59.10.1016/S0022-5347(01)66448-6  [Google Scholar]  [CrossRef]

[34]Patki P, Woodhouse J, Hamid R, Craggs M, Shah J, Effects of spinal cord injury on semen parameters J Spinal Cord Med 2008 31(1):27-32.10.1080/10790268.2008.11753977  [Google Scholar]  [CrossRef]

[35]Cohen DR, Basu S, Randall JM, Aballa TC, Lynne CM, Brackett NL, Sperm motility in men with spinal cord injuries is enhanced by inactivating cytokines in the seminal plasma J Androl 2004 25(6):922-25.10.1002/j.1939-4640.2004.tb03162.x15477364  [Google Scholar]  [CrossRef]  [PubMed]

[36]Collinger JL, Foldes S, Bruns TM, Wodlinger B, Gaunt R, Weber DJ, Neuroprosthetic technology for individuals with spinal cord injury J Spinal Cord Med 2013 36(4):258-72.10.1179/2045772313Y.000000012823820142  [Google Scholar]  [CrossRef]  [PubMed]

[37]Shan H, Chen F, Zhang T, He S, Xu L, Weil A, Stem cell therapy for erectile dysfunction of cavernous nerve injury rats: A systematic review and meta-analysis PLoS One 2015 10(4):e012142810.1371/journal.pone.012142825860455  [Google Scholar]  [CrossRef]  [PubMed]